MPO’s Most Read March Articles

March’s top 10 articles included MPO featured articles, business changes and announcements, regulatory news, and product news.
 
This month’s features on medical device materials, EU regulations, diabetes technology, and new blood collection technology gained a lot of traction. Robotics, digital health, sustainability, and point-of-care testing are among the myriad of issues shaping the medtech materials sector. The EU’s new regulations are causing more OEM requests for testing and laboratory services. 
 
In business news, Johnson Matthey has begun a deal to sell its MDC business to Montagu Private Equity for $700 million. Also, Siemens Healthineers is closing its Fast Track Diagnostics’ portfolio due to its drop since the peak of the COVID-19 pandemic.
 
Abbott released real-world data that supports its FreeStyle Libre CGM for people with Type 2 diabetes. The FDA approved Sequel’s twist drug delivery system that measures the volume and flow of insulin in every micro-dose. BD also released a new blood collection system that can simplify the process for patients to get blood drawn for testing. 
 
 
1. A Matter of Fact for Medical Device Materials

2. Sequel’s twiist Automated Insulin Delivery System Wins FDA OK

3. Johnson Matthey to Sell Medical Device Components Biz for $700M

4. Evaluations for the EU: The Impact on Testing & Lab Services

5. Former Medical Device Company CEO Convicted of Selling Fake Components

6. Norwood Medical Appoints Gregg Olson VP of Sales and Marketing

7. The Sweet Science of Diabetes Technology

8. Siemens Healthineers to Close Fast Track Diagnostics Biz

9. Abbott’s Real-World Data Backs FreeStyle Libre CGM Use with GLP-1s

10. Putting Blood Collection at Patients’ Fingertips… Literally